These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26585899)

  • 41. A pharmacometric case study regarding the sensitivity of structural model parameter estimation to error in patient reported dosing times.
    Knights J; Rohatagi S
    J Pharmacokinet Pharmacodyn; 2015 Dec; 42(6):627-37. PubMed ID: 26209956
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes.
    Herman GA; Bergman A; Yi B; Kipnes M;
    Curr Med Res Opin; 2006 Oct; 22(10):1939-47. PubMed ID: 17022853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigations of a compartmental model for leucine kinetics using non-linear mixed effects models with ordinary and stochastic differential equations.
    Berglund M; Sunnåker M; Adiels M; Jirstrand M; Wennberg B
    Math Med Biol; 2012 Dec; 29(4):361-84. PubMed ID: 21965323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigating the contribution of residual unexplained variability components on bias and imprecision of parameter estimates in population pharmacokinetic mixed-effects modeling.
    Jaber MM; Brundage RC
    J Pharmacokinet Pharmacodyn; 2023 Apr; 50(2):123-132. PubMed ID: 36617366
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-linear mixed-effects pharmacokinetic/pharmacodynamic modelling in NLME using differential equations.
    Tornøe CW; Agersø H; Jonsson EN; Madsen H; Nielsen HA
    Comput Methods Programs Biomed; 2004 Oct; 76(1):31-40. PubMed ID: 15313540
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
    Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
    J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phase-step estimation in interferometry via an unscented Kalman filter.
    Zander TE; Madyastha V; Patil A; Rastogi P; Reindl LM
    Opt Lett; 2009 May; 34(9):1396-8. PubMed ID: 19412284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. State estimation of stochastic non-linear hybrid dynamic system using an interacting multiple model algorithm.
    Elenchezhiyan M; Prakash J
    ISA Trans; 2015 Sep; 58():520-32. PubMed ID: 26303958
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An in vitro--in silico--in vivo approach in biopharmaceutical drug characterization: metformin hydrochloride IR tablets.
    Beloica S; Cvijić S; Homšek I; Bogataj M; Parojčić J
    Pharmazie; 2015 Jul; 70(7):458-65. PubMed ID: 26373206
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Uncertainty propagation for deterministic models of biochemical networks using moment equations and the extended Kalman filter.
    Kurdyaeva T; Milias-Argeitis A
    J R Soc Interface; 2021 Aug; 18(181):20210331. PubMed ID: 34343452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Using stochastic differential equations for PK/PD model development.
    Kristensen NR; Madsen H; Ingwersen SH
    J Pharmacokinet Pharmacodyn; 2005 Feb; 32(1):109-41. PubMed ID: 16215845
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical development of metformin extended-release tablets for type 2 diabetes: an overview.
    Schwartz SL; Gordi T; Hou E; Cramer M; Heritier M; Cowles VE
    Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1235-43. PubMed ID: 18721117
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biowaiver approach for biopharmaceutics classification system class 3 compound metformin hydrochloride using in silico modeling.
    Crison JR; Timmins P; Keung A; Upreti VV; Boulton DW; Scheer BJ
    J Pharm Sci; 2012 May; 101(5):1773-82. PubMed ID: 22334460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A methodological paradigm for patient-specific multi-scale CFD simulations: from clinical measurements to parameter estimates for individual analysis.
    Pant S; Fabrèges B; Gerbeau JF; Vignon-Clementel IE
    Int J Numer Method Biomed Eng; 2014 Dec; 30(12):1614-48. PubMed ID: 25345820
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stochastic stability of sigma-point Unscented Predictive Filter.
    Cao L; Tang Y; Chen X; Zhao Y
    ISA Trans; 2015 Jul; 57():189-204. PubMed ID: 25744052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of food on the pharmacokinetics of canagliflozin/metformin (150/1,000 mg) immediate-release fixed-dose combination tablet in healthy participants.
    Murphy J; Wang SS; Stieltjes H; Wajs E; Devineni D
    Int J Clin Pharmacol Ther; 2015 Mar; 53(3):256-64. PubMed ID: 25546166
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Saxagliptin/metformin (kombiglyze XR) for type 2 diabetes.
    Med Lett Drugs Ther; 2011 Mar; 53(1360):21-2. PubMed ID: 21412207
    [No Abstract]   [Full Text] [Related]  

  • 58. Nonlinear Mixed-Effects Models for PET Data.
    Chen Y; Goldsmith J; Ogden RT
    IEEE Trans Biomed Eng; 2019 Mar; 66(3):881-891. PubMed ID: 30072311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inferring microbial interaction networks from metagenomic data using SgLV-EKF algorithm.
    Alshawaqfeh M; Serpedin E; Younes AB
    BMC Genomics; 2017 Mar; 18(Suppl 3):228. PubMed ID: 28361680
    [TBL] [Abstract][Full Text] [Related]  

  • 60. REML estimation of variance parameters in nonlinear mixed effects models using the SAEM algorithm.
    Meza C; Jaffrézic F; Foulley JL
    Biom J; 2007 Dec; 49(6):876-88. PubMed ID: 17638294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.